PRO-MOMETASONE DIN 02566613
Health Canada record
| Active ingredient(s) | MOMETASONE FUROATE 50 MCG |
|---|---|
| Dosage form | Spray (Metered-Dose) |
| Route | Nasal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | R01AD09 MOMETASONE |
| Original market date | |
| Current status date | 10-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pro Doc Limitée — licence 100182, currently licensed, last inspection rating C (2025-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MOMETASONE FUROATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02403587 | APO-MOMETASONE | APOTEX INC | Spray (Metered-Dose) | MOMETASONE FUROATE 50 MCG | Marketed |
| 02438690 | ASMANEX TWISTHALER | ORGANON CANADA INC. | Powder | MOMETASONE FUROATE 100 MCG | Marketed |
| 02243595 | ASMANEX TWISTHALER | ORGANON CANADA INC. | Powder | MOMETASONE FUROATE 200 MCG | Marketed |
| 02243596 | ASMANEX TWISTHALER | ORGANON CANADA INC. | Powder | MOMETASONE FUROATE 400 MCG | Marketed |
| 00851744 | ELOCOM | ORGANON CANADA INC. | Cream | MOMETASONE FUROATE 0.1 % | Marketed |
| 00851736 | ELOCOM | ORGANON CANADA INC. | Ointment | MOMETASONE FUROATE 0.1 % | Marketed |
| 00871095 | ELOCOM | ORGANON CANADA INC. | Lotion | MOMETASONE FUROATE 0.1 % | Marketed |
| 02451905 | NASAL ALLERGY AND CONGESTION RELIEF | APOTEX INC | Spray (Metered-Dose) | MOMETASONE FUROATE 50 MCG | Approved |
| 02238465 | NASONEX | ORGANON CANADA INC. | Spray (Metered-Dose) | MOMETASONE FUROATE 50 MCG | Marketed |
| 02244768 | PMS-MOMETASONE | PHARMASCIENCE INC | Lotion | MOMETASONE FUROATE 0.1 % | Approved |
| 02244767 | PMS-MOMETASONE | PHARMASCIENCE INC | Cream | MOMETASONE FUROATE 0.1 % | Approved |
| 02367157 | TARO-MOMETASONE CREAM | TARO PHARMACEUTICALS INC | Cream | MOMETASONE FUROATE 0.1 % | Marketed |
| 02266385 | TARO-MOMETASONE LOTION | TARO PHARMACEUTICALS INC | Lotion | MOMETASONE FUROATE 0.1 % | Marketed |
| 02248130 | TEVA-MOMETASONE | TEVA CANADA LIMITED | Ointment | MOMETASONE FUROATE 0.1 % | Marketed |
| 02475863 | TEVA-MOMETASONE | TEVA CANADA LIMITED | Spray (Metered-Dose) | MOMETASONE FUROATE 50 MCG | Marketed |
| 02361760 | ZENHALE | ORGANON CANADA INC. | Aerosol (Metered-Dose) | MOMETASONE FUROATE 200 MCG; FORMOTEROL FUMARATE DIHYDRATE 5 MCG | Marketed |
| 02361752 | ZENHALE | ORGANON CANADA INC. | Aerosol (Metered-Dose) | MOMETASONE FUROATE 100 MCG; FORMOTEROL FUMARATE DIHYDRATE 5 MCG | Marketed |
| 02410524 | NASONEX ALLERGY AND CONGESTION | MERCK CANADA INC | Spray (Metered-Dose) | MOMETASONE FUROATE 50 MCG | Cancelled Pre Market |
| 02244769 | PMS-MOMETASONE | PHARMASCIENCE INC | Ointment | MOMETASONE FUROATE 0.1 % | Cancelled Post Market |
| 02270862 | PMS-MOMETASONE | PHARMASCIENCE INC | Ointment | MOMETASONE FUROATE 0.1 % | Cancelled Post Market |
| 02264749 | TARO-MOMETASONE OINTMENT | TARO PHARMACEUTICALS INC | Ointment | MOMETASONE FUROATE 0.1 % | Dormant |
| 02361744 | ZENHALE | ORGANON CANADA INC. | Aerosol (Metered-Dose) | MOMETASONE FUROATE 50 MCG; FORMOTEROL FUMARATE DIHYDRATE 5 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37071 | 2026-03-10 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for MOMETASONE FUROATE
14 valid EDQM Certificates of Suitability from 13 holders. 35 active FDA Drug Master Files.
Request a quote for PRO-MOMETASONE